Skip to content
DraconiticResearch
Search Sources API
194,220 studies31 sourcesUpdated 32 min ago
Peer-reviewedCC BYDiagnostics (Basel, Switzerland)

Prognostic Significance of p53 Immunohistochemical Expression and Molecular Characterization of TP53 Variants in Triple-Negative Breast Cancer After Neoadjuvant Chemotherapy

6 affiliations
  1. 1Department of Medical Oncology, Hospital de Denia, 03700 Alicante, Spain;
  2. 2PASAPTA Department, Veterinary School, Universidad Cardenal Herrera-CEU, CEU Universities, Alfara del Patriarca, 46115 Valencia, Spain; (L.Á.); (I.T.-C.); (J.M.G.-B.)
  3. 3Department of Obstetrics and Gynecology, La Ribera Salud, 46015 Sueca, Spain;
  4. 4Department of Mathematics, Physics and Technological Sciences, Universidad Cardenal Herrera-CEU, CEU Universities, 46115 Valencia, Spain; (R.B.-R.); (J.P.); (A.F.)
  5. 5School of Health Sciences, Universidad Cardenal Herrera-CEU, CEU Universities, Alfara del Patriarca, 45115 Valencia, Spain;
  6. 6Department of Pathology, Hospital de Denia, 03700 Alicante, Spain;

Related

  1. Immunohistochemical Classification and Prognostic Significance of Germinal Center-like and Memory Cell-like Subtypes of Follicular Lymphoma Using FOXP1, LMO2, CD22, and MUM1.
    Tülay Koç, Sedanur Aydın, Zeynep Öztürk +1
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Identification of Candidate Partner Cells in Tumor–Stromal Interactions by Histology-Based Spatial Analysis for Prognostic Stratification After Neoadjuvant Chemotherapy
    Naing Ye Aung, Takanobu Kabasawa, Yuki Hamada +2
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  3. Splenic Enlargement During Neoadjuvant Chemotherapy for Gastric Cancer: Treatment-Related Phenomenon or Prognostic Biomarker?
    Ezgi Altınsoy, Veysel Cem Özcan, Abdurrahman Başpınar +4
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  4. Prognostic significance of lymph node staging in esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy
    Herui Han, Xiaobin Hou, Yiming Liu +7
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefDOAJ
  5. Therapeutic outcomes and prognostic determinants of neoadjuvant chemotherapy plus interval debulking surgery compared with primary debulking surgery in advanced-stage epithelial ovarian cancer
    Yan Ma, Mengli Xu, Qi Zhang +2
    Frontiers in oncologyPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCCrossref
BibTeX
@article{berenguermari2026prognostic,
  title = {{Prognostic Significance of p53 Immunohistochemical Expression and Molecular Characterization of TP53 Variants in Triple-Negative Breast Cancer After Neoadjuvant Chemotherapy}},
  author = {Juan Ramón Berenguer-Marí and Luis Álvarez and Julia Sierra-Roca and Raquel Bosch-Romeu and Irene Tadeo-Cervera and Juan Pardo and Antonella Locascio and Juan Bautista Laforga and Antonio Falcó and Juan Manuel Gasent-Blesa and Joan Climent},
  journal = {Diagnostics (Basel, Switzerland)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13663948},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Prognostic Significance of p53 Immunohistochemical Expression and Molecular Characterization of TP53 Variants in Triple-Negative Breast Cancer After Neoadjuvant Chemotherapy
AU  - Juan Ramón Berenguer-Marí
AU  - Luis Álvarez
AU  - Julia Sierra-Roca
AU  - Raquel Bosch-Romeu
AU  - Irene Tadeo-Cervera
AU  - Juan Pardo
AU  - Antonella Locascio
AU  - Juan Bautista Laforga
AU  - Antonio Falcó
AU  - Juan Manuel Gasent-Blesa
AU  - Joan Climent
PY  - 2026
DA  - 2026/10/01
JO  - Diagnostics (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13663948
SN  - 2075-4418
ER  -